Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 230
Selected: 0
NCT IDTitle
NCT01557010Evaluate the Efficacy and Safety of DWP05195 in Subjects With Post-Herpetic Neuralgia
NCT07144176PK and Safety Comparison of DWJ1511 and DWC202501 in Healthy Volunteers
NCT05378360DWP708 for Treating Epidermal Growth Factor Receptor Inhibitor Related Skin Toxicities
NCT05149274Evaluate the Pharmacokinetics and Safety of DWP14012 Tablet A and Compare Those of DWP14012 Tablet B in Healthy Subjects
NCT04926623Freestyle Libre-based Education on MDI in T2DM (FreEdoM-2)
NCT05832697An Exploratory Clinical Trial to Evaluate and Compare Safety and Pharmacokinetic Characteristics After Administration of the DWJ1439, DWJ1464, DWC202108 or DWC202109 in Healthy Adult Volunteers
NCT04613895Treatment Effect According to Timing of Administration of DWP14012 40 mg
NCT06025409Evaluate the Efficacy and Safety of DWJ108J
NCT05926414To Evaluate the Efficacy and Safety of Envlo Tablet or Envlomet SR Tablet in Patients With Type II Diabetes Mellitus
NCT01397240The Safety and Efficacy of Albis®: The Prevention of Aspirin-induced Gastrointestinal Ulcers in Patients
NCT02693522Evaluation of Efficacy and Safety of Recombinant Somatroipn in Patients With Growth Hormone Deficiency
NCT01713920Efficacy and Tolerability of Combination Antihypertensive Drug in Non-Responders to ARB monoTHerapy Using 24h ABPM
NCT04185805Pharmacokinetics and Safety of DWP14012 Tablet A and Tablet B in Healthy Volunteers (III)
NCT03573622A Single-dose, Comparative Bioavailability Study of Two Formulations of Sarpogrelate HCl 300mg Tablets Under Fasting Conditions
NCT05816681Assessment of Elemental Impurities Level After Multiple Administration of DWJ1230 or DWB2001 in Subjects With Functional Diarrhea or Irritable Bowel Syndrome With Predominant Diarrhea.
NCT05643508A Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of DWC202206 and DWC202207 in Patients With Concomitant Hypertension and Hyperlipidemia
NCT03574285A Single-dose, Comparative Bioavailability Study of Two Formulations of Sarpogrelate HCl 300mg Tablets Under Feeding Conditions
NCT04003441Pharmacokinetics and Safety of DWP14012 Tablet A and Tablet B in Healthy Volunteers
NCT03224117Clinicial Trial to Evaluate the Efficacy and Safety of DWJ211 in Patient With Moderate or Severe Submental Fat
NCT05661552Effect of Early Initiation of Evolocumab on Lipid Profiles Changes in Patients With ACS Undergoing PCI
NCT04721535A Study of DWJ1248 in Prevention of COVID-19 Infection After the Exposure of SARS-COV-2
NCT06031987Long-term Effects of Flash Glucose Monitoring System in Patients With Gestational Diabetes
NCT05411887Study to Evaluate the Effect of Improving Systolic BP and LDL-C Compared to Conventional Treatments and the Convenience of Taking Medication of Olostar Tab
NCT04819932Pharmacokinetics and Safety of DWJ1451 in Healthy Adults
NCT00969787DWP05195 in Healthy Adult Male Volunteers
NCT02241850Genetic Polymorphisms Affecting Effect of High Intensity Training
NCT06751121Study to Evaluate the Efficacy and Safety of DWP14012-based Triple Therapy in Eradication of Helicobacter Pylori
NCT07619833To Evaluate the Efficacy and Safety of Initial Combination Therapy With DWP16001 and DWC202518 Compared to DWP16001 Monotherapy and DWC202518 Monotherapy in Patients With Type 2 Diabetes Mellitus
NCT03517319Dose-response Relationship of Botullinum Toxin (DWP 450) for Finger Flexor Spasticity
NCT03946592Evaluate the Efficacy and Safety of DWJ211 in Patient With Moderate or Severe Submental Fat
NCT02069717Observational Study to Assess the Incidence Rate of the Major Adverse Cardiovascular Events (MACE) and Safety of Fenofibrate (Lipilfen Capsule)
NCT03364985Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP16001 After Oral Administration in Healthy Male Volunteers
NCT05574374Drug-drug Interactions Between DWP14012 and DWC202202 in Healthy Subjects
NCT02415777Clinical Trial to Evaluate the Efficacy and Safety of 'URSA SOFT CAP. (UDCA-003)' in Fatigue Patients With Liver Dysfunction
NCT03947528Bioavailability Study of Two Formulations of Sarpogrelate HCl 300mg Tablets Under Fed Conditions
NCT05660122A Study to Evaluate the Improvement Effect on Subjective Symptom of FEXUCLUE Tab
NCT03016494Safety and Pharmacokinetics Study of Fixed Dose Combination of DWJ1386 Compared With Co-administration of DWC20155 and DWC20156 in Healthy Subjects
NCT04888819Treatment Effect According to Timing of Administration of DWP14012 40 mg
NCT07558707Fexuclue for Prevention of NSAIDs-Induced Peptic Ulcer in Real-World Practice
NCT01094834A Multiple Dose Study of DWP05195 in Healthy Adult Subjects
NCT02952755Drug-Drug Interaction Study Between DWC20155 / DWC20156 and DWC20162 in Healthy Volunteers
NCT05465668Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic Characteristics of DWP16001 Drug A and C
NCT04772443Evaluate the Efficacy and Safety of DWJ1506 and DWJ1507
NCT07326904Study Comparing Fexuprazan and Esomeprazole in Patients With Gastroesophageal Reflux Disease
NCT02568150Evaluation Onset Time of DWP450-004 and Safety in Moderate-severe Glabellar Lines
NCT07260851Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1622, DWC202313, and DWC202314 in Healthy Volunteers Under Fasting Conditions
NCT01634321The Clinical Trial to Evaluate the Efficacy and Safety of Luphere Depot Inj. 3.75mg(Leuprolide Acetate 3.75mg) in Patients With Precocious Puberty
NCT07267221Bioequivalence Study for the Safety and the Pharmacokinetics of DWC202313, DWC202314, and DWJ1622 in Healthy Volunteers Under Fed Condition.
NCT04524052To Evaluate Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of DWRX2003 Against COVID-19
NCT05845489Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- CloPidogREl for Primary preVENTION (HOST-PREVENTION)